4.4 Article

Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome

Journal

VETERINARY PATHOLOGY
Volume 58, Issue 5, Pages 981-993

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/0300985821996671

Keywords

osteosarcoma; dogs; periostin; immunohistochemistry; gene expression

Funding

  1. National Institutes of Health, Office of the Director [K01ODO22982, R03OD028265]
  2. Short-Term National Research Award [T35OD015130]
  3. National Center for Advancing Translational Sciences [L30 TR002126]
  4. Boehringer Ingelheim Veterinary Scholar Fellowship

Ask authors/readers for more resources

Periostin is an important matricellular protein involved in regulating bone, tooth, and cardiac development, but also plays a role in inflammatory diseases and certain cancers. In this study, periostin expression was found to be significantly upregulated in canine osteosarcoma tumors, but not associated with time to metastasis. Tumors with high periostin expression showed activation of pro-tumorigenic pathways, while tumors with low periostin expression showed enhanced anti-tumor immune responses.
Periostin is a matricellular protein important in regulating bone, tooth, and cardiac development. In pathologic conditions, periostin drives allergic and fibrotic inflammatory diseases and is also overexpressed in certain cancers. Periostin signaling in tumors has been shown to promote angiogenesis, metastasis, and cancer stem cell survival in rodent models, and its overexpression is associated with poor prognosis in human glioblastoma. However, the role of periostin in regulating tumorigenesis of canine cancers has not been evaluated. Given its role in bone development, we sought to evaluate mRNA and protein expression of periostin in canine osteosarcoma (OS) and assess its association with patient outcome. We validated an anti-human periostin antibody cross-reactive to canine periostin via western blot and immunohistochemistry and evaluated periostin expression in microarray data from 49 primary canine OS tumors and 8 normal bone samples. Periostin mRNA was upregulated greater than 40-fold in canine OS tumors compared to normal bone and was significantly correlated with periostin protein expression based on quantitative image analysis. However, neither periostin mRNA nor protein expression were associated with time to metastasis in this cohort. Gene Set Enrichment Analysis demonstrated significant enhancement of pro-tumorigenic pathways including canonical WNT signaling, epithelial-mesenchymal transition, and angiogenesis in periostin-high tumors, while periostin-low tumors demonstrated evidence of heightened antitumor immune responses. Overall, these data identify a novel antibody that can be used as a tool for evaluation of periostin expression in dogs and suggest that investigation of Wnt pathway-targeted drugs in periostin overexpressing canine OS may be a potential therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available